Pfizer’s High Dividend Yield Attracts Investors Despite Stock Decline

Pfizer Inc. (PFE) offers a compelling case for investment with its recent dividend yield soaring to 7.4%. A $10,000 investment WOULD yield approximately $740 annually, while a $30,000 stake could generate $2,220 in yearly income. The company has consistently increased its dividend, from $1.12 per share in 2015 to $1.71 recently.

Despite the attractive yield, Pfizer's stock has declined by 18% over the past year, partly due to upcoming patent expirations for key drugs like Eliquis, Prevnar, and Ibrance. The company is countering this challenge by bolstering its drug pipeline, particularly in oncology, following its acquisition of Seagen.

COVID-19-related products, once significant revenue drivers, now face uncertain demand. However, Pfizer's strategic moves and robust dividend policy continue to draw investor interest.